Thomas Danne

1993–2025 年に発表

131
論文数
19,665
被引用数
67
h 指数
127
i10 指数

被引用数

Thomas Danne の年別被引用数1991 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 5 件1995 年: 被引用 3 件1996 年: 被引用 6 件1997 年: 被引用 7 件1998 年: 被引用 6 件1999 年: 被引用 11 件2000 年: 被引用 10 件2001 年: 被引用 16 件2002 年: 被引用 13 件2003 年: 被引用 23 件2004 年: 被引用 34 件2005 年: 被引用 37 件2006 年: 被引用 40 件2007 年: 被引用 43 件2008 年: 被引用 55 件2009 年: 被引用 69 件2010 年: 被引用 26 件2011 年: 被引用 40 件2012 年: 被引用 35 件2013 年: 被引用 62 件2014 年: 被引用 106 件2015 年: 被引用 68 件2016 年: 被引用 79 件2017 年: 被引用 74 件2018 年: 被引用 180 件2019 年: 被引用 572 件2020 年: 被引用 763 件2021 年: 被引用 801 件2022 年: 被引用 692 件2023 年: 被引用 677 件2024 年: 被引用 1,102 件2025 年: 被引用 553 件2026 年: 被引用 27 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,689 件、この内訳の 22.3%イギリス: 引用元論文 681 件、この内訳の 9%ドイツ: 引用元論文 435 件、この内訳の 5.7%イタリア: 引用元論文 429 件、この内訳の 5.7%オーストラリア: 引用元論文 335 件、この内訳の 4.4%カナダ: 引用元論文 284 件、この内訳の 3.8%中国: 引用元論文 283 件、この内訳の 3.7%デンマーク: 引用元論文 265 件、この内訳の 3.5%スペイン: 引用元論文 209 件、この内訳の 2.8%スウェーデン: 引用元論文 204 件、この内訳の 2.7%フランス: 引用元論文 183 件、この内訳の 2.4%オランダ: 引用元論文 176 件、この内訳の 2.3%
0%22.3%その他 31.7%

分野

  • Medicine84%
  • Biochemistry, Genetics and Molecular Biology10%
  • Health Professions2.1%
  • Engineering0.9%
  • Computer Science0.7%
  • Psychology0.4%
  • その他1.9%

トピック

  • Diabetes Management and Research24.7%
  • Diabetes and associated disorders12.5%
  • Pancreatic function and diabetes12.4%
  • Diabetes Treatment and Management7.2%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients6.7%
  • Diabetes Management and Education3.2%
  • その他33.3%

共著者

全論文

検索で開く
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 被引用: 3,797

  2. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E Umpierrez, Stuart A. Weinzimer, Moshe Phillip - The Lancet Diabetes & Endocrinology 2022 被引用: 725

  3. International Consensus on Use of Continuous Glucose Monitoring

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2017 被引用: 2,026

  4. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 被引用: 402

  5. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev - Journal of Diabetes Science and Technology 2022 被引用: 276

  6. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 328

  7. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 被引用: 237

  8. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 416

  9. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2019 被引用: 356

  10. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minu George, Edgar R. Gonzalez, Michael Gottschalk, Giancarlo Guido, Amir Ali Hassan, Eli Hershkovitz, Lina Huerta‐Saenz, Jin Soon Hwang, Jaime Orlando Ibarra Gomez, Lydia Irizarry Gonzalez, Nina Jain, David H. Jelley, Ho-Seong Kim, T. A. Kovalenko, Lori M. Laffel, Steven B. Leichter, Raphael Del Roio Liberatore, Jane Lynch, Farid H. Mahmud, Oleg Arturovich Malievskiy, Andrew Muir, Bryce Nelson, Luis Alejandro Nevarez Ruiz, Micah L. Olson, Emilia Susana Pelayo Orozco, Valentina Peterkova, Fernando Ramón Ramírez Mendoza, Konda Mohan Reddy, Henry Rodriguez, Javier Andres Saenz, Julia Samoilova, Karl‐Otfried Schwab, S Shah, Naim Shehadeh, Ashley H. Shoemaker, Yulia Skorodok, Aleksandr Sobolev, Silvana Ernestina Solís, Shylaja Srinivasan, William V. Tamborlane, Eva Tsalikian, Ф. В. Валеева, Carl D Vance, Pedro Velasquez‐Mieyer, R. Ortiz, Olga Votyakova, Haiyan Wei, Ruth S. Weinstock, Mark D. Wheeler, Brandy Wicklow, Steven M. Willi, Kupper A. Wintergerst, Risa M. Wolf, Jamie Wood, Chandan Yaliwal, Hernán Yupanqui Lozno - The Lancet Diabetes & Endocrinology 2023 被引用: 103

  11. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

    著者: , , , , , , , , , , , , , , - Diabetes Care 2018 被引用: 228

  12. Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetes Care 2024 被引用: 68

  13. HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

    著者: , , , , , , , , , , , - Diabetes Care 2018 被引用: 183

  14. New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes

    著者: , , , , , , , , , , , - Diabetes Care 2009 被引用: 314

  15. The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes

    著者: , , , , , , , , , - Diabetes Technology & Therapeutics 2021 被引用: 105

  16. ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes

    著者: , , , , , , , , , , - Pediatric Diabetes 2022 被引用: 88

  17. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetologia 2024 被引用: 58

  18. Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

    著者: , , , - Diabetes Technology & Therapeutics 2018 被引用: 104

  19. Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

    著者: , , , , , , , - The Journal of Pediatrics 2016 被引用: 122

  20. Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Gerard‐Gonzalez, Melanie Cree‐Green, Susan J. Gross, Shideh Majidi, Laurel H. Messer, Tyler Reznick-Lipina, Emily Simmons, Katie Thivener, Isabel Weber, Steven M. Willi, Terri H. Lipman, Olena Kucheruk, Pantea Minnock, Cathy Carchidi, Brian Grant, Diana R. Olivos, Linda A. DiMeglio, Tamara S. Hannon, Carmella Evans‐Molina, David W. Hansen, Tina M. Pottorff, Stephanie L. Woerner, Megan Hildinger, Robin Hufferd, America Newnum, Devyn Purtlebaugh, Lisa Smith, Kathleen Wendholt, Robin Goland, Rachelle Gandica, Kristen M. Williams, Sarah Pollack, Emily Casciano, Julia Hochberg, Cecilia Uche, Joyce M. Lee, Brigid Gregg, Meng H. Tan, Lynn Ang, Rodica Pop‐Busui, Inas H. Thomas, Emily Dhadphale, Janet Dominowski, Ashley Garrity, Virginia Leone, Cynthia Plunkett, Brittany Plunkett, Roshanak Monzavi, Clement S.K. Cheung, Lynda K. Fisher, Mimi S. Kim, Brian Miyazaki, Pisit Pitukcheewanont, Anna Sandström, Juliana Austin, Nancy Change, Jennifer K. Raymond, Brian Ichihara, Megan Lipton, Jaquelin Flores Garcia, Satish K. Garg, Aaron W. Michels, Rachel Garcetti, Melanie Cree‐Green, Raymond Gutin, Kristen J. Nadeau, Sarit Polsky, Viral N. Shah, Mary Voelmle, L. Daniel Myers ほか 499 名 - Diabetes Care 2019 被引用: 94

  21. The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

    著者: , , , , , , , , , , , - Diabetes Technology & Therapeutics 2020 被引用: 143

  22. INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Cnop, Søren Brunak, Flemming Pociot, Jesper Johannesen, Peter Rossing, C. Legido Quigley, Roberto Mallone, Raphaël Scharfmann, Christian Boîtard, Mikael Knip, Timo Otonkoski, Riitta Veijola, Riitta Lahesmaa, M. Oresic, Jorma Toppari, Thomas Danne, Anette‐Gabriele Ziegler, Peter Achenbach, T. Rodriguez-Calvo, Michele Solimena, Ezio Bonifacio, Stephan Speier, Reinhard W. Holl, Francesco Dotta, F. Chiarelli, P. Marchetti, Emanuele Bosi, Stefano Cianfarani, Paolo Ciampalini, Carine de Beaufort, Knut Dahl‐Jørgensen, Torild Skrivarhaug, Geir Joner, L. Krogvold, Przemysława Jarosz‐Chobot, Tadej Battelino, B. Thorens, Martin Gotthardt, Bart O. Roep, Tatjana Nikolić, Arnaud Zaldumbide, Åke Lernmark, Markus Lundgren, Guillaum Costecalde, T. Strube, Anke M. Schulte, Almut Nitsche, Matthias von Herrath, Johnna D. Wesley, Antonella Napolitano-Rosen, Marius Thomas, Nanette C. Schloot, A. Goldfine, Frank Waldron-Lynch, J. Kompa, A. Vedala, N. Hartmann, Gwenaelle Nicolas, Jean Van Rampelbergh, N. Bovy, Srijana Dutta, John Soderberg, Simi Ahmed, Frank B. Martin, G. Agiostratidou, A. Koralova, Ruben H. Willemsen, Anne Smith, Bawani Anand, V. Puthi ほか 40 名 - Trials 2022 被引用: 39

  23. C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial

    著者: , , , , , , , , , - Diabetes Obesity and Metabolism 2022 被引用: 36

  24. Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis

    著者: , , , , , , , , , , - BMC Nephrology 2021 被引用: 33